South Korea faces shortage of pediatric influenza treatments

The Korean Pediatric and Adolescent Hospital Association has issued an urgent call for government intervention due to a severe shortage of pediatric influenza treatments. As influenza cases surge earlier than usual, liquid formulations and powders essential for young children are facing widespread stockouts at the wholesale level.

Choi Yong-jae, president of the association, noted that many liquid products have not been manufactured this year, leaving only depleted existing stocks. This shortage forces medical professionals to prescribe capsules instead, which are difficult for young children to swallow. Attempting to open capsules to mix the powder with food often results in vomiting due to the bitter taste, complicating treatment.

Because influenza medication is most effective when administered within 48 hours of symptom onset, delays in securing medicine increase the risk of complications such as pneumonia, febrile seizures, and encephalitis, particularly in children under five. The association is calling for a dedicated management system for essential pediatric medicines, official guidance on alternative administration methods, and a pricing structure that reflects actual production costs to ensure stable supply and distribution.